Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules

<div>ROI was drawn on the level of maximum transactional diameter of hemangioma (green circle). (a, b) Axial fat suppress T2WI and T1WI. (c–e) Dynamic enhancement imaging included artery phase, portal phase, and hepatobiliary phase (HBP). (f, g) Axial liver DWI (<i>b</i> = 800 s/mm<sup>2</sup>) and ADC maps. (h–j) Axial liver DKI (<i>b</i> = 2000 s/mm<sup>2</sup>) and DKI-derived parameters <i>K</i> and <i>D</i> maps.</div>

Contrast Media & Molecular Imaging

fig4

Figure 4

Figure 4: Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules 

Figure 4 | Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules 